share_log

HC Wainwright & Co. Reiterates Buy on Altimmune, Maintains $15 Price Target

Benzinga ·  Dec 1, 2023 14:28

HC Wainwright & Co. analyst Patrick Trucchio reiterates Altimmune (NASDAQ:ALT) with a Buy and maintains $15 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment